Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 October 2019 | Story Ruan Bruwer | Photo Varsity Sports
Lefebere and Khanyisa
Lefébre Rademan (left) and Khanyisa Chawane before the start of the Varsity Netball clash. Rademan was named the Player of the Tournament, a reward Chawane received last year.

For the sixth time in the seven years of the competition, the best player in the Varsity Netball tournament hails from the University of the Free State (UFS).

Lefébre Rademan, captain of the Kovsie netball team who ended third in Varsity Netball, was named as the Player of the Tournament and the Players’ Player of the Tournament on Monday night (7 October). Previous UFS recipients of the award are Ané Bester (2013), Karla Pretorius (in 2014 and 2015), Khomotso Mamburu (2016), and Khanyisa Chawane (2018).

Rademan shot 176 goals from 214 attempts for a goal average of 82%. In both the Premier League and National Championship, she received the prize for the best shooter this year.

The news comes shortly after the announcement that a UFS teammate has secured a contract to play overseas next year. Khanyisa Chawane, who impressed immensely as a member of the Proteas at this year’s World Cup, will represent Bath in Europe’s Superleague. The 23-year-old Chawane also received an offer to play in the Australian league, but the one in England suited her better.

She will return to Bloemfontein midway through the year and will still be available for the Kovsie netball team, as she will continue her studies. The talented mid-courter follows in the footsteps of Pretorius, who also spent a season with Bath in 2016.

“I am really thrilled to have signed with Bath. There is no doubt that I’m going to come out a better player; I’m grateful to have been scouted and given this opportunity to play for such a big team. It still brings tears to my eyes when I think about it.”

“My goal has always been to play abroad and to challenge myself. I always strive to better myself and give my best on and off court,” Chawane said about the opportunity next year.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept